The Stelo CGM is meant to give Type 2 diabetics who don’t need insulin a more affordable way to monitor their blood sugar. The Stelo CGM is meant to give Type 2 diabetics who don’t need insulin a more ...

Dexcom (DXCM) is leveraging AI to drive operational efficiency and product innovation, positioning itself as a platform ...

We first reported on Stelo at CES 2024, and 8 months on, it’s now available in the US without a prescription. Unlike the company’s existing G7 CGM, Stelo is designed for adults 18+ who are not on ...

Add Yahoo as a preferred source to see more of our stories on Google. Four years ago, my life changed after a heart attack at the age of 33. While a quick coronary angioplasty meant my heart was ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...

Glucose monitoring specialist Dexcom is expanding its partnership with health-tracking ring maker Oura to provide Stelo users and ring wearers with metabolic health features, including meal insights ...

DexCom Inc. DXCM recently announced the availability of Stelo, the first over-the-counter (OTC) continuous glucose monitoring (CGM) biosensor in the United States. The biosensor is available for ...

Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is ...

As of this week, consumers can order Dexcom Inc.’s Stelo continuous glucose monitor (CGM) online without a prescription, making it the first to hit the market. Dexcom will have competition soon, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Back at CES 2024, we wrote about the Dexcom Stelo – a new continuous glucose monitor (CGM) aimed at pre-diabetics and Type 2 sufferers. Stelo has now been cleared by the FDA and will be the first over ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...